NVS

Recent Articles

10 Pharmaceuticals Stocks to Sell Now

The ratings of 10 Pharmaceuticals stocks are down this week, according to the Portfolio Grader database. Each of these rates a "D" ("sell") or "F" overall ("strong sell"). More 

Broker Darlings of the Dow: Pfizer Inc. (PFE)

A study of recommendations at the major brokerages shows Pfizer is the #7 broker pick, out of the 30 stocks in the Dow More 

Johnson & Johnson: My Favorite Dividend King (JNJ)

Johnson & Johnson is one of the strongest dividend payers the market's have to offer. Here's why I'm willing to pay a premium to own JNJ stock More 

Intellia Therapeutics IPO: The “Biggest Biotech Discovery of the Century”

Intellia Therapeutics' upcoming IPO could bring "the biggest biotech discovery of the century" to a down-and-out biotech sector. More 

Novartis AG (ADR) (NVS) Under Investigation for ‘Sham’ Events

Novartis is under investigation for alleged 80,000 sham events it held for doctors as part of a case concerning illegal kickbacks. More 

Why Johnson & Johnson Is a Top Dow Pick (JNJ)

A study of analyst recommendations shows that Johnson & Johnson is the #17 broker pick, on average, out of the 30 stocks making up the Dow More 

STUDY: Dementia Risk Linked to Popular Heartburn Drugs

Several heartburn drugs known as proton pump inhibitors are being linked to increased risk of dementia, according to a study published JAMA Neurology. More